home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

3.515 +0.005 (+0.14%)

Streaming Delayed Price Updated: 12:17 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Nasdaq Gains 100 Points Following PCE Data ↗

February 29, 2024

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the...

Via Benzinga

Topics Stocks

PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture ↗

February 29, 2024

Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture.

Via InvestorPlace

Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All ↗

February 29, 2024

The company still plans to ask for approval of its short bowel syndrome treatment.

Via Investor's Business Daily

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge ↗

February 29, 2024

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.

Via Benzinga

Topics Economy Stocks

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

A Preview Of Ironwood Pharmaceuticals's Earnings ↗

February 14, 2024

Via Benzinga

Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? ↗

February 29, 2024

Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 29, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

Via InvestorPlace

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

February 29, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Chart Of The Day: Ironwood Pharma - Gastrointestinal Products ↗

February 13, 2024

Via Talk Markets

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

February 23, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Top 4 Health Care Stocks You May Want To Dump In February ↗

February 15, 2024

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance

February 15, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call

February 01, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation

January 08, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

January 08, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

December 12, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

November 30, 2023

Dallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to...

Via Newsfile

Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Reports Third Quarter 2023 Results

November 09, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call

October 26, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting

October 23, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week

October 16, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old

October 05, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday ↗

September 19, 2023

U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance

August 08, 2023

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com